Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
The price revision, effective April 3, 2026, brings the innovator molecule within the reach of a significantly larger patient base across the country
This marks a meaningful step in the company's continued expansion in the region
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
The programme aims to provide critical healthcare services to approximately 4 lakh people in remote and resource-scarce communities
Subscribe To Our Newsletter & Stay Updated
